Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Gross Profit (2020 - 2025)

Biofrontera (BFRI) has 5 years of Gross Profit data on record, last reported at $4.9 million in Q3 2025.

  • For Q3 2025, Gross Profit fell 44.68% year-over-year to $4.9 million; the TTM value through Sep 2025 reached $23.9 million, up 63.42%, while the annual FY2024 figure was $18.7 million, 12.55% up from the prior year.
  • Gross Profit reached $4.9 million in Q3 2025 per BFRI's latest filing, down from $6.4 million in the prior quarter.
  • Across five years, Gross Profit topped out at $40.1 million in Q2 2022 and bottomed at -$7.3 million in Q4 2022.
  • Average Gross Profit over 5 years is $6.7 million, with a median of $5.3 million recorded in 2025.
  • The widest YoY moves for Gross Profit: up 601.0% in 2022, down 181.57% in 2022.
  • A 5-year view of Gross Profit shows it stood at $9.0 million in 2021, then crashed by 181.57% to -$7.3 million in 2022, then skyrocketed by 78.43% to -$1.6 million in 2023, then skyrocketed by 560.97% to $7.3 million in 2024, then crashed by 32.18% to $4.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $4.9 million in Q3 2025, $6.4 million in Q2 2025, and $5.3 million in Q1 2025.